Yuta Ohgi
Tokushima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Synergistic Effect of Combination Treatment of Brexpiprazole and Nalmefene on Ethanol Intake in Rats.
Journal: Neuropsychopharmacology reports
Published: June 06, 2025
Alcohol dependence and opioid receptor -Pharmacological profile of nalmefene
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Published: May 08, 2020
Brexpiprazole has a low risk of dopamine D2 receptor sensitization and inhibits rebound phenomena related to D2 and serotonin 5-HT2A receptors in rats.
Journal: Neuropsychopharmacology reports
Published: June 05, 2019
Increased BDNF-TrkB signaling in the nucleus accumbens plays a role in the risk for psychosis after cannabis exposure during adolescence.
Journal: Pharmacology, biochemistry, and behavior
Published: December 18, 2018
Alterations in amino acid levels in mouse brain regions after adjunctive treatment of brexpiprazole with fluoxetine: comparison with (R)-ketamine.
Journal: Psychopharmacology
Published: April 11, 2017
Adjunctive treatment of brexpiprazole with fluoxetine shows a rapid antidepressant effect in social defeat stress model: Role of BDNF-TrkB signaling.
Journal: Scientific reports
Published: September 28, 2016
Antidepressant effects of combination of brexpiprazole and fluoxetine on depression-like behavior and dendritic changes in mice after inflammation.
Journal: Psychopharmacology
Published: July 06, 2016
Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction hypothesis.
Journal: Molecular psychiatry
Published: June 10, 2015
Global Trends in Alzheimer Disease Clinical Development: Increasing the Probability of Success.
Journal: Clinical therapeutics
Published: April 15, 2015
Synthesis of nano-TaO(x) oxygen reduction reaction catalysts on multi-walled carbon nanotubes connected via a decomposition of oxy-tantalum phthalocyanine.
Journal: Physical chemistry chemical physics : PCCP
Published: March 03, 2015
Glutamate Signaling in Synaptogenesis and NMDA Receptors as Potential Therapeutic Targets for Psychiatric Disorders.
Journal: Current molecular medicine
Published: November 24, 2014
Potentiation of neurite outgrowth by brexpiprazole, a novel serotonin-dopamine activity modulator: a role for serotonin 5-HT1A and 5-HT2A receptors.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: April 04, 2014
Last Updated: 09/26/2026